Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

In the July 2 release, 4DMT explained that the 25% layoffs are part of a move to “streamline operations to offset additional ...

Catalio Capital Management has closed its fourth venture fund with more than $400 million that will be used in part to launch ...

University of Minnesota spinout Fasikl has obtained an FDA clearance for its artificial-intelligence-powered wearable for ...

The pulsed field ablation developer Kardium has collected $250 million in funding to gear up for the commercial expansion of ...

AN Venture Partners has closed its first fund, a $200 million vault for biotechs worldwide, with particular emphasis on ...

On Wednesday, Biokin reported (PDF) positive topline results from a phase 3 trial of the ADC. The study enrolled patients ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, urging the agency not to impose new restrictions on its use as an abortion ...

AbbVie is on board with the idea. The Big Pharma will pay up to $2.1 billion in cash at closing to acquire Capstan. In return ...

Storied Japanese pharma Shionogi is upping its arsenal in the fight against antibiotic resistance. | Storied Japanese pharma ...

After claiming an FDA approval last year, Intuitive has obtained a greenlight in Europe for its latest surgical robot, the da ...

Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...